University of Minnesota Medical School

Content by University of Minnesota Medical School

|1 min read

Novel Drug Improves Rare Kidney Disorder in Phase 3 Trial

Some 42 percent of patients treated with sparsentan showed reduced proteinuria
|2 min read

Identifying Patients with Sarcoidosis at Risk for Bad Cardiac Outcomes

Patients with certain features seen on an MRI may benefit from an implantable cardioverter defibrillator
|2 min read

Study Establishes the Value of Cardiovascular MRI for Suspected Cardiac Tumors

The U of M Medical School study concludes that CMR should be the technique of choice
Page 1 of 1